Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $1.4 million.

  • Krystal Biotech's Depreciation & Amortization (CF) rose 769.23% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 873.38%. This contributed to the annual value of $6.0 million for FY2024, which is 1983.22% up from last year.
  • Latest data reveals that Krystal Biotech reported Depreciation & Amortization (CF) of $1.4 million as of Q3 2025, which was up 769.23% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Depreciation & Amortization (CF) registered a high of $1.8 million during Q2 2024, and its lowest value of $536000.0 during Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $1.1 million, with a median of $1.0 million in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first plummeted by 3054.19% in 2023, then skyrocketed by 10241.13% in 2024.
  • Quarter analysis of 5 years shows Krystal Biotech's Depreciation & Amortization (CF) stood at $784000.0 in 2021, then skyrocketed by 38.9% to $1.1 million in 2022, then surged by 38.38% to $1.5 million in 2023, then decreased by 7.3% to $1.4 million in 2024, then increased by 0.21% to $1.4 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.4 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.4 million for Q1 2025.